(-0.01%) 5 213.00 points
(-0.01%) 39 022 points
(-0.02%) 18 196 points
(-0.59%) $77.92
(0.36%) $2.22
(0.09%) $2 326.30
(0.26%) $27.62
(-0.12%) $987.20
(0.09%) $0.930
(0.32%) $10.93
(0.16%) $0.801
(-1.11%) $90.43
0.00% $ 0.317
Live Chart Being Loaded With Signals
Integrated Diagnostics Holdings plc, a consumer healthcare company, provides various medical diagnostics services to patients. It offers approximately 2,000 diagnostic test services, including immunology, microbiology, hematology, endocrinology, clinical chemistry, molecular biology, cytogenetics, histopathology, and radiology...
Stats | |
---|---|
Volumen de hoy | 2.42M |
Volumen promedio | 325 174 |
Capitalización de mercado | 190.20M |
EPS | $0 ( 2023-11-20 ) |
Próxima fecha de ganancias | ( $0 ) 2024-05-29 |
Last Dividend | $0.0490 ( 2021-07-08 ) |
Next Dividend | $0 ( N/A ) |
P/E | 15.85 |
ATR14 | $0 (0.00%) |
Integrated Diagnostics Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Integrated Diagnostics Finanzas
Annual | 2023 |
Ingresos: | $4.12B |
Beneficio Bruto: | $1.52B (36.98 %) |
EPS: | $0.850 |
FY | 2023 |
Ingresos: | $4.12B |
Beneficio Bruto: | $1.52B (36.98 %) |
EPS: | $0.850 |
FY | 2022 |
Ingresos: | $3.61B |
Beneficio Bruto: | $1.46B (40.56 %) |
EPS: | $0.900 |
FY | 2021 |
Ingresos: | $5.22B |
Beneficio Bruto: | $2.80B (53.67 %) |
EPS: | $2.35 |
Financial Reports:
No articles found.
Integrated Diagnostics Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $0.0150 | 2016-04-07 |
Last Dividend | $0.0490 | 2021-07-08 |
Next Dividend | $0 | N/A |
Payout Date | 2021-07-29 | |
Next Payout Date | N/A | |
# dividends | 6 | -- |
Total Paid Out | $0.230 | -- |
Avg. Dividend % Per Year | 0.90% | -- |
Score | 3.44 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 4.25 | |
Div. Directional Score | 8.38 | -- |
Year | Amount | Yield |
---|---|---|
2016 | $0 | 0.00% |
2017 | $0 | 0.00% |
2018 | $0.0400 | 3.34% |
2019 | $0.0440 | 4.18% |
2020 | $0.0468 | 4.65% |
2021 | $0.0490 | 4.45% |
2022 | $0 | 0.00% |
2023 | $0 | 0.00% |
2024 | $0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
RICO.L | Dividend Knight | 2023-09-28 | Semi-Annually | 17 | 1.55% | |
HAS.L | Dividend Knight | 2023-10-05 | Annually | 32 | 2.18% | |
ASCI.L | Dividend Knight | 2023-09-28 | Quarterly | 32 | 1.83% | |
UPGS.L | Dividend Knight | 2023-06-01 | Semi-Annually | 8 | 2.42% | |
MIG5.L | Dividend Knight | 2023-06-22 | Semi-Annually | 24 | 4.45% | |
CYN.L | Dividend Knight | 2023-09-21 | Quarterly | 30 | 2.73% | |
SEPL.L | Dividend Royal | 2023-08-16 | Bi-Monthly | 11 | 9.82% | |
IBM.L | Dividend King | 2023-08-09 | Quarterly | 17 | 3.30% | |
BGLF.L | Dividend King | 2023-08-03 | Quarterly | 9 | 6.38% | |
WWH.L | Dividend Junior | 2023-06-08 | Semi-Annually | 29 | 0.48% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.124 | 1.500 | 7.52 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0884 | 1.200 | 7.05 | 8.46 | [0 - 0.3] |
returnOnEquityTTM | 0.201 | 1.500 | 8.88 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 1.539 | 0.800 | 7.31 | 5.85 | [1 - 3] |
quickRatioTTM | 1.103 | 0.800 | 8.22 | 6.57 | [0.8 - 2.5] |
cashRatioTTM | 0.529 | 1.500 | 8.17 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.174 | -1.500 | 7.10 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 12.76 | 1.000 | 6.38 | 6.38 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.906 | 2.00 | 9.70 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.365 | 2.00 | 9.82 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.374 | -1.500 | 8.50 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.370 | 1.000 | 7.17 | 7.17 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.218 | 1.000 | 7.64 | 7.64 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.542 | 1.000 | 8.10 | 8.10 | [0.2 - 2] |
assetTurnoverTTM | 0.714 | 0.800 | 8.57 | 6.86 | [0.5 - 2] |
Total Score | 12.52 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 17.87 | 1.000 | 8.30 | 0 | [1 - 100] |
returnOnEquityTTM | 0.201 | 2.50 | 9.28 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.365 | 2.00 | 9.88 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.906 | 2.00 | 9.70 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0 | 1.500 | -3.33 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.132 | 1.000 | 9.20 | 0 | [0.1 - 0.5] |
Total Score | 4.25 |
Integrated Diagnostics
Integrated Diagnostics Holdings plc, a consumer healthcare company, provides various medical diagnostics services to patients. It offers approximately 2,000 diagnostic test services, including immunology, microbiology, hematology, endocrinology, clinical chemistry, molecular biology, cytogenetics, histopathology, and radiology. The company operates in Egypt, Jordan, Sudan, and Nigeria. As of December 30, 2021, it operated a network of 452 branch labs. The company was founded in 1979 and is headquartered in Saint Helier, Jersey.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico